Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
2026 - 01 - 05
Maryam Hatami appointed to the Executive Board of Berlin-Chemie AG for Technical Operations
Berlin, 5 January 2026 – The Supervisory Board of Berlin-Chemie AG has appointed Maryam Hatami to the company's Executive Board with effect from 1 January 2026. She will take over as Head of Technical Operations, which encompasses the key areas of production, quality management, logistics/supply chain management and technology. Maryam Hatami succeeds Dr. Stefano Papa, who had previously held interim responsibility for Technical Operations.
Maryam Hatami has been with Berlin-Chemie since 2012 and was most recently responsible for Quality Control, where she played a key role in ensuring high quality standards. By taking on additional responsibilities in Technical Operations in recent months, she has gained extensive experience for her new position.
‘We warmly welcome Maryam Hatami to the Executive Board,’ said Han Steutel, Chairman of the Board of Berlin-Chemie AG. ‘With her proven experience and expertise, she will successfully drive forward the further development of Technical Operations and make an important contribution to the future direction of the company.’
‘I am delighted about the trust placed in me and the opportunity to take on responsibility for Technical Operations,’ said Maryam Hatami. ‘Together with my team, my goal is not only to consistently continue the successful processes at Berlin-Chemie and ensure our high standards in production, quality and supply chain, but also to implement innovative approaches.’
The Supervisory Board would like to express its sincere thanks to Dr. Stefano Papa for his great commitment during his interim role at Berlin-Chemie and wishes him all the best and every success in his global role within the Menarini Group.
About Berlin-Chemie
Berlin-Chemie AG is an internationally active, research-based pharmaceutical company founded in 1890 and based in Berlin-Adlershof. Since 1992, the company has been a subsidiary of the Italian Menarini Group and is responsible within the group for the primary care business in Germany and in over 30 countries in Central and Eastern Europe and Central Asia. The group's largest production site is located in Berlin, where high-quality medicines are manufactured for over 90 countries worldwide. Berlin-Chemie generated sales of €1.48 billion in 2024 and employs around 1,500 people in the Berlin-Brandenburg region.
Contact
Alessandro Grua
Head of Regional Communications & PR
mediarelations@berlin-chemie.de